Managing Obesity with Mounjaro- A Brief Literature Review

Radwa Clarissa Omar
Additional contact information
Radwa Clarissa Omar: Vanderbilt University, Kentucky Friendly Care Center, USA

Biomedical Journal of Scientific & Technical Research, 2023, vol. 52, issue 2, 43569-43571

Abstract: Mounjaro (tirzepatide) is both a glucagon like peptide (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist that was developed for the treatment of Type 2 Diabetes Mellitus (T2DM). Mounjaro was approved in May 2022 by the United State Food and Drug Administration (USFDA) as the first and the only GLP-1 and GIP receptor agonist to treat T2D. Obesity and diabetes are becoming an increasing global problem, particularly in Western populations, referenced as the twin epidemics.

Keywords: Journals on Medical Drug and Therapeutics; Journals on Emergency Medicine; Physical Medicine and Rehabilitation; Journals on Infectious Diseases Addiction Science and Clinical Pathology; Open Access Clinical and Medical Journal; Journals on Biomedical Science; List of Open Access Medical Journal; Journals on Biomedical Engineering; Open Access Medical Journal; Biomedical Science Articles; Journal of Scientific and Technical Research (search for similar items in EconPapers)
Date: 2023
References: Add references at CitEc
Citations:

Downloads: (external link)
https://biomedres.us/pdfs/BJSTR.MS.ID.008226.pdf (application/pdf)
https://biomedres.us/fulltexts/BJSTR.MS.ID.008226.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:abf:journl:v:52:y:2023:i:2:p:43569-43571

DOI: 10.26717/BJSTR.2023.52.008226

Access Statistics for this article

Biomedical Journal of Scientific & Technical Research is currently edited by Robert Thomas

More articles in Biomedical Journal of Scientific & Technical Research from Biomedical Research Network+, LLC
Bibliographic data for series maintained by Angela Roy ().